Queen Elizabeth Hospital Birmingham selects RayStation
Queen Elizabeth Hospital Birmingham (QEHB), a pioneering UK hospital, has selected the RayStation® treatment planning system following an extensive evaluation of market-leading systems. The agreement includes both clinical and research licenses, and the installation will include adaptive planning, multi-criteria optimization, automated breast planning, scripting and radiobiology.
QEHB is part of University Hospitals Birmingham NHS Foundation Trust, which is one of the largest regional centers for non-surgical cancer treatment in the UK. The center offers a high degree of sub-specialization by tumor site and treats patients from the whole of the British Isles and from overseas. The radiation therapy department at QEHB has some of the most advanced facilities available in the UK; its equipment portfolio includes six linacs, two TomoTherapy systems and a CyberKnife system. RayStation has the flexibility and compatibility needed to meet the future planning needs of such a leading-edge center with a broad range of treatment machines.
Jason Cashmore, head of treatment planning at QEHB, says: “A thorough evaluation made it clear that RayStation was the best solution to meet our needs now and in the long term. Its processing speed, coupled with advanced automation and scripting capabilities, will enable us to optimize adaptive planning workflows and save significant clinician time.”
Johan Löf, CEO of RaySearch, says: “We look forward to working with Queen Elizabeth Hospital Birmingham and to providing a unified platform for all its radiation treatment planning. The team at QEHB has a clear direction toward automation and adaptive planning and also operates diverse and advanced treatment equipment. This is exactly the kind of environment in which RayStation excels.”
About Queen Elizabeth Hospital Birmingham
Queen Elizabeth Hospital Birmingham (QEHB), run by University Hospitals Birmingham NHS Foundation Trust (UHB), is recognized as one of the leading hospitals in Europe and has an international reputation for quality of care, informatics/IT, clinical training and research. QEHB provides direct clinical services to more than 1 million patients every year, serving a regional, national and international population. In addition to its specialist cancer center, UHB has the largest solid organ transplantation program in Europe and is a major specialist center for burns, plastic surgery and neurosciences.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon-ion therapy. The system is built using the latest software development principles and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare®, which comprises a new product area for RaySearch, and which will be launched in 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on NASDAQ Stockholm since November 2003.
More information about RaySearch is available at www.raysearchlabs.com
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00